The challenge

• Interdependencies between P&R and other development & commercialization strategies
• Multiple indications, with different price implications, for single molecules
• Portfolio management and decision impact
• Leveraging portfolio in price negotiations
  
  
  
  

• Economic and clinical maps: multiple, interrelated purchase decision makers with unique needs and pressures
• Mix of regulated and free market systems, even within single countries
• Cross market commercial and P&R impacts via parallel trade, price referencing
  
  
  
  
  

Effective management requires an applied understanding of this dynamic system of interactions that is relevant to your product or portfolio